Latest North Carolina News

Page 3 of 4
Nufarm Limited has announced Rico Christensen as its new CEO, effective January 2026, succeeding Greg Hunt who will stay on as advisor until mid-2026. Christensen brings three decades of global agricultural sector expertise and a strong operational focus.
Ada Torres
Ada Torres
19 Nov 2025
Arovella Therapeutics reported solid progress in Q1 FY26, moving closer to initiating its first-in-human trial for ALA-101 while securing key patents and maintaining a strong cash position.
Ada Torres
Ada Torres
30 Oct 2025
Elevra Lithium has completed a transformative merger and maintained robust production at its North American Lithium operation, while unveiling a compelling expansion plan that could boost output by 55% and slash costs.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Silex Systems announces that its exclusive licensee, Global Laser Enrichment, has achieved a critical technology milestone for its laser uranium enrichment process, enabling plans for a new US enrichment facility to advance.
Maxwell Dee
Maxwell Dee
23 Oct 2025
Lithium Universe Limited has unveiled plans for a second lithium carbonate refinery in Brownsville, Texas, complementing its flagship Québec project and aiming to ease North America's lithium supply bottleneck.
Maxwell Dee
Maxwell Dee
14 Oct 2025
Arovella Therapeutics has demonstrated that its novel CLDN18.2 CAR-T cells effectively eliminate pancreatic cancer cells in vitro, matching the performance of a leading competitor’s product. The company is now advancing this CAR into its innovative iNKT cell platform to tackle solid tumours.
Ada Torres
Ada Torres
2 Oct 2025
Global Laser Enrichment, Silex’s exclusive licensee, has completed large-scale uranium enrichment testing, advancing the SILEX technology closer to commercial deployment in the US nuclear fuel market.
Maxwell Dee
Maxwell Dee
17 Sept 2025
BCAL Diagnostics has launched its first commercial breast cancer diagnostic test, BREASTESTplus™, in Australia, marking a key milestone despite a $7.24 million loss for FY2025. The company is also advancing its US operations with a new subsidiary and clinical trials underway.
Ada Torres
Ada Torres
29 Aug 2025
BluGlass Limited reported a 16% rise in revenue to $11.7 million for FY25, driven by key US Department of Defense contracts and new partnerships. However, the company’s net loss increased 8% to nearly $11 million amid ongoing R&D investment and operational scaling.
Sophie Babbage
Sophie Babbage
27 Aug 2025
Acusensus Limited reported a 20% increase in revenue to $59.35 million for FY25, driven by new and expanded contracts across Australia, New Zealand, the US, and the UK. However, net losses widened by 72.3%, reflecting higher operating expenses and ongoing litigation costs.
Sophie Babbage
Sophie Babbage
26 Aug 2025
Arovella Therapeutics reported a 14% reduction in net loss to $7.5 million for FY25, bolstered by a $15 million capital raise to fund its lead iNKT cell therapy program progressing toward a pivotal phase 1 clinical trial.
Ada Torres
Ada Torres
22 Aug 2025
Piedmont Lithium reported strong Q2 2025 operational results with record production at North American Lithium and $11.9 million revenue, while shareholder voting on its merger with Sayona Mining has been adjourned to August 11.
Maxwell Dee
Maxwell Dee
8 Aug 2025

Browse the archive

Full archive